Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic ...

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that its ...

Detailed price information for Precision Biosciences Inc (DTIL-Q) from The Globe and Mail including charting and trades.

Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentations at the upcoming 18th Clinical ...

New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the ...

Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase 2 and Phase 3 clinical ...

Whether your family is affected by Alzheimer's or you simply want to learn more about the disease, this conference in Boca ...

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Internal records reveal that for years Penn State’s clinical cancer research was mired in deep-rooted and potentially ...

BioLife Solutions ( ($BLFS) ) has issued an update. On November 17, 2025, BioLife Solutions released an investor presentation highlighting its ...

The latest update is out from Purple Biotech ( (PPBT) ).